Mucosal inflammation in severe glucocorticoid-dependent asthma

European Respiratory Journal

Volumn 13, Issue 6, 1999, Pages 1245-1252

  Vrugt, B ^a,b   Wilson, S ^c   Underwood, J ^c   Bron, A ^a   De Bruyn, R ^a   Bradding, P ^c   Holgate, S T ^a   Djukanovic, R ^c   Aalbers, R ^a  

^a Dutch Asthma Centre   (Switzerland)

^b MARTINI HOSPITAL   (Netherlands)

^c NONE

Author keywords

Glucocorticoids; Severe asthma; T cell activation

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CD3 ANTIGEN; CD4 ANTIGEN; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; PREDNISOLONE; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; BUDESONIDE; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MALE; MAST CELLS; MIDDLE AGED; MUCOUS MEMBRANE; PEAK EXPIRATORY FLOW RATE; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0032793229     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13f06.x     Document Type: Article

References (34)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. State of the art. Am Rev Respir Dis 1990; 142: 434-457.
2. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-942.
3. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
4. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma before and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806-817.
5. Aalbers R, de Monchy JGR, Kauffman HF, et al. Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction. Eur Respir J 1993; 6: 840-847.
6. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
7. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5 and -6 and tumor necrosis factor alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Cell Mol Biol 1994; 10: 471-480.
8. Kuwano K, Bosken CH, Paré PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
9. Saetta M, DiStefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138-143.
10. Corrigan CJ, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991; 144: 1026-1032.
11. Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay AB, Corrigan CJ. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax 1994; 49: 1231-1233.
12. Sher ER, Leung DYM, Surs W, et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93: 33-39.
13. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016-1025.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
15. Woolcock AJ. Management of asthma in adults. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma. Basic Mechanisms and Clinical Management. 2nd Edn. London, Academic Press, 1992; pp. 679-699.
16. NHLBI/WHO Workshop Report. NHLBI Global Strategy for Asthma Management and Prevention. Publication No.95-3659, 1995.
17. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423-429.
18. Djukanovic R, Wilson JW, Lai CKW, Holgate ST, Howarth PH. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991; 143: 772-777.
19. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993; 68: 271-280.
20. Bradding P, Feather IH, Howarth PH, et al. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992; 176: 1381-1386.
21. McNamee LA, Fattah DI, Baker TJ, Bains TJ, Hissey PH. Production, characterisation and use of monoclonal antibodies to interleukin 5 in an enzyme-linked immunosorbent assay. J Immunol Methods 1991; 141: 81-88.
22. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-674.
23. Djukanovic R, Homeyard S, Gratziou C, et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med 1997; 155: 826-832.
24. Wilson JW, Djukanovic R, Howarth PH, Holgate ST. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 1994; 149: 86-90.
25. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-406.
26. Chanez P, Paradis L, Vignola AM, et al. Changes in bronchial inflammation of steroid (Gcs) dependent asthmatics. Am J Respir Crit Care Med 1996; 153: 212.
27. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156: 737-743.
28. Pouliot M, McDonald PP, Borgerat P, McColl SR. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med 1994; 179: 1225-1232.
29. Leung DYM, Martin RJ, Szefler SJ, et al. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J Exp Med 1995; 181: 33-40.
30. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leucocyte. Annu Rev Med 1993; 44: 85-101.
31. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997; 156: 1377-1383.
32. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78: 2542-2547.
33. Shute JK, Vrugt B, Lindley IJD, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997; 155: 1877-1883.
34. Naseer T, Minshall EM, Leung DYM, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997; 155: 845-851.